Evidence map›Paper›PMID 35994460›Full record

ArticlePloS one2022

Intracranial approach for sub-second monitoring of neurotransmitters during DBS electrode implantation does not increase infection rate.

Brittany Liebenow, Michelle Williams, Thomas Wilson, Ihtsham Ul Haq, Mustafa S Siddiqui, Adrian W Laxton, Stephen B Tatter, Kenneth T Kishida

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Brittany LiebenowNeuroscience Graduate Program, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.ORCID 0000-0003-2451-6530
Michelle WilliamsDepartment of Neurosurgery, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
Thomas WilsonDepartment of Neurosurgery, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
Ihtsham Ul HaqDepartment of Neurology, University of Miami Miller School of Medicine, Miami, FL, United States of America.
Mustafa S SiddiquiDepartment of Neurology, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
Adrian W LaxtonDepartment of Neurosurgery, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
Stephen B TatterDepartment of Neurosurgery, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.
Kenneth T KishidaNeuroscience Graduate Program, Wake Forest School of Medicine, Winston-Salem, NC, United States of America.ORCID 0000-0002-7394-8922
Wake Forest University · USUniversity of Miami · US

Funding

Wake Forest Clinical and Translational Science AwardKL2TR001421 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MILLER, DAVID P · 2015 to 2023
$5.8M
Computational and electrochemical substrates of social decision-making in humansR01MH124115 · NIMH · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI GU, XIAOSI, KISHIDA, KENNETH TUCKER · 2020 to 2024
$5.1M
Dopaminergic encoding of counterfactual information in human striatumR01NS092701 · NINDS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI MONTAGUE, P READ · 2015 to 2019
$2.6M
Neuro-computational Approach to Determine a Neurochemical Basis of Mood and DepressionR01MH121099 · NIMH · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KISHIDA, KENNETH TUCKER · 2019 to 2023
$1.9M
Real-time neurochemical encoding of reward- and punishment-prediction errors and associated subjective experiences in humansR01DA048096 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KISHIDA, KENNETH TUCKER · 2019 to 2023
$1.7M
Dopamine's Role in Impulse Control and Reward Learning in HumansF30DA053176 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI LIEBENOW, BRITTANY · 2021 to 2024
$185k
NCATS NIH HHS KL2 TR001421NIDA NIH HHS F30 DA053176NIDA NIH HHS R01 DA048096NIMH NIH HHS R01 MH121099NIMH NIH HHS R01 MH124115NINDS NIH HHS R01 NS092701
6 · The paper itself

Abstract

introductionCurrently, sub-second monitoring of neurotransmitter release in humans can only be performed during standard of care invasive procedures like DBS electrode implantation. The procedure requires acute insertion of a research probe and additional time in surgery, which may increase infection risk. We sought to determine the impact of our research procedure, particularly the extended time in surgery, on infection risk.

methodsWe screened 602 patients who had one or more procedure codes documented for DBS electrode implantation, generator placement, programming, or revision for any reason performed at Wake Forest Baptist Medical Center between January 2011 through October 2020 using International Classification of Diseases (ICD) codes for infection. During this period, 116 patients included an IRB approved 30-minute research protocol, during the Phase 1 DBS electrode implantation surgery, to monitor sub-second neurotransmitter release. We used Fisher's Exact test (FET) to determine if there was a significant change in the infection rate following DBS electrode implantation procedures that included, versus those that did not include, the neurotransmitter monitoring research protocol.

resultsWithin 30-days following DBS electrode implantation, infection was observed in 1 (0.21%) out of 486 patients that did not participate in the research procedure and 2 (1.72%) of the 116 patients that did participate in the research procedure. Notably, all types of infection observed were typical of those expected for DBS electrode implantation.

conclusionInfection rates are not statistically different across research and non-research groups within 30-days following the research procedure (1.72% vs. 0.21%; p = 0.0966, FET). Our results demonstrate that the research procedures used for sub-second monitoring of neurotransmitter release in humans can be performed without increasing the rate of infection.

Indexed as

Deep Brain StimulationElectrodes, ImplantedHumansNeurotransmitter AgentsNeurotransmitter Agents

Identifiers

PMID35994460
PMCPMC9394791
OpenAlexW4292636103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.